LSL Pharma Group Inc. (TSXV:LSL)
Canada · Delayed Price · Currency is CAD 0.3600
0.00 (0.00%)
Jul 21, 2026, 10:03 AM EST
LSL Pharma Group Market Cap
LSL Pharma Group has a market cap or net worth of CAD 45.62 million as of July 21, 2026. Its market cap has decreased by -8.17% in one year.
Market Cap
45.62M
Enterprise Value
83.42M
Revenue
28.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.36
ChartMarket Cap Chart
Since March 2, 2023, LSL Pharma Group's market cap has decreased from 61.67M to 45.62M, a decrease of -26.02%. That is a compound annual growth rate of -8.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 45.62M | 7.53% |
| Dec 31, 2025 | 42.43M | -10.43% |
| Dec 31, 2024 | 47.37M | 18.48% |
| Dec 29, 2023 | 39.98M | -35.17% |
| Mar 2, 2023 | 61.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vext Science | 63.16M |
| Grey Wolf Health | 55.19M |
| Charlotte's Web Holdings | 51.39M |
| BioNxt Solutions | 47.62M |
| ZYUS Life Sciences | 39.86M |
| Optimi Health | 39.38M |
| C21 Investments | 37.98M |
| Mountain Valley MD Holdings | 36.56M |